<

SANOFI-AVENTIS (EPA:SAN) Press Release: FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection

Transparency directive : regulatory news

23/02/2023 22:00



Other stories

15/06/2024 20:05
15/06/2024 23:37
15/06/2024 18:41
15/06/2024 23:53
15/06/2024 20:24
14/06/2024 18:03
15/06/2024 18:40
15/06/2024 22:25
15/06/2024 20:34
15/06/2024 17:40
15/06/2024 20:15
15/06/2024 18:50
15/06/2024 22:19
15/06/2024 17:17
14/06/2024 21:54
14/06/2024 19:03
15/06/2024 12:55
15/06/2024 07:07
15/06/2024 20:05
15/06/2024 13:57
14/06/2024 08:19
15/06/2024 19:00
15/06/2024 21:30
16/06/2024 00:25
15/06/2024 22:40
15/06/2024 22:15
16/06/2024 00:15
15/06/2024 23:11
15/06/2024 23:29
15/06/2024 13:33
15/06/2024 18:43
14/06/2024 21:04
15/06/2024 22:15
14/06/2024 20:18
15/06/2024 18:25
14/06/2024 18:33
14/06/2024 16:37
15/06/2024 16:00